Literature DB >> 19720100

Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?

Mariana G Rosca1, Hélène Lemieux1, Charles L Hoppel1.   

Abstract

Endogenous acetylcarnitine is an indicator of acetyl-CoA synthesized by multiple metabolic pathways involving carbohydrates, amino acids, fatty acids, sterols, and ketone bodies, and utilized mainly by the tricarboxylic acid cycle. Acetylcarnitine supplementation has beneficial effects in elderly animals and humans, including restoration of mitochondrial content and function. These effects appear to be dose-dependent and occur even after short-term therapy. In order to set the stage for understanding the mechanism of action of acetylcarnitine, we review the metabolism and role of this compound. We suggest that acetylation of mitochondrial proteins leads to a specific increase in mitochondrial gene expression and mitochondrial protein synthesis. In the aged rat heart, this effect is translated to increased cytochrome b content, restoration of complex III activity, and oxidative phosphorylation, resulting in amelioration of the age-related mitochondrial defect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720100      PMCID: PMC4120470          DOI: 10.1016/j.addr.2009.06.009

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  159 in total

1.  Dietary thioproline decreases spontaneous food intake and increases survival and neurological function in mice.

Authors:  Ana Navarro; Maria Jesús Sánchez-Pino; Carmen Gómez; Manuel J Bández; Enrique Cadenas; Alberto Boveris
Journal:  Antioxid Redox Signal       Date:  2007-01       Impact factor: 8.401

2.  Aging impairs skeletal muscle mitochondrial bioenergetic function.

Authors:  Pedro A Figueiredo; Scott K Powers; Rita M Ferreira; Hans Joachim Appell; José A Duarte
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-05       Impact factor: 6.053

3.  Carnitine acetyltransferase: the question of multiple forms.

Authors:  Y H Edwards; J F Chase; M R Edwards; P K Tubbs
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.

Authors:  Stuart A Montgomery; L J Thal; R Amrein
Journal:  Int Clin Psychopharmacol       Date:  2003-03       Impact factor: 1.659

Review 5.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

6.  Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle.

Authors:  A Barrientos; J Casademont; A Rötig; O Miró; A Urbano-Márquez; P Rustin; F Cardellach
Journal:  Biochem Biophys Res Commun       Date:  1996-12-13       Impact factor: 3.575

7.  Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria.

Authors:  Ulla F Rasmussen; Peter Krustrup; Michael Kjaer; Hans N Rasmussen
Journal:  Exp Gerontol       Date:  2003-08       Impact factor: 4.032

8.  Myocardial ischemia: correlation of mitochondrial adenine nucleotide and respiratory function.

Authors:  G K Asimakis; V R Conti
Journal:  J Mol Cell Cardiol       Date:  1984-05       Impact factor: 5.000

9.  Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis.

Authors:  C L Hoppel; S M Genuth
Journal:  Am J Physiol       Date:  1982-08

10.  Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release.

Authors:  Mohammed Aldakkak; David F Stowe; Qun Chen; Edward J Lesnefsky; Amadou K S Camara
Journal:  Cardiovasc Res       Date:  2008-01-15       Impact factor: 10.787

View more
  28 in total

Review 1.  Novel mitochondrial targets for neuroprotection.

Authors:  Miguel A Perez-Pinzon; R Anne Stetler; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-28       Impact factor: 6.200

Review 2.  A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

Authors:  Nahla E El-Ashmawy; Rania M Khalil
Journal:  Tumour Biol       Date:  2013-12-12

Review 3.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

Review 4.  An animal model to study human muscular diseases involving mitochondrial oxidative phosphorylation.

Authors:  Hélène Lemieux; Blair E Warren
Journal:  J Bioenerg Biomembr       Date:  2012-06-16       Impact factor: 2.945

Review 5.  Mitochondrial Metabolism in Aging Heart.

Authors:  Edward J Lesnefsky; Qun Chen; Charles L Hoppel
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

6.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

Review 7.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28

Review 8.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

Review 9.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

Review 10.  Psychological Stress and Mitochondria: A Conceptual Framework.

Authors:  Martin Picard; Bruce S McEwen
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.